HomeMarket NewsALPN Stock Report: Alpine Immune Sciences Shines with Strong Q4 2023 Performances

ALPN Stock Report: Alpine Immune Sciences Shines with Strong Q4 2023 Performances

Actionable Trade Ideas

always free

ALPN stock - ALPN Stock Report: Alpine Immune Sciences Shines with Strong Q4 2023 Performances

Source: iQoncept / Shutterstock

Alpine Immune Sciences (NASDAQ:ALPN) has left analysts awe-struck with its fourth-quarter 2023 financial results.

  • Reporting a substantial earnings per share of 15 cents, Alpine Immune Sciences startled the market, surpassing the projected EPS of -34 cents.
  • The company’s revenue of $30.85 million has sent ripples through the industry, boasting a staggering 239.04% beat compared to the anticipated revenue of $9.10 million.

InvestorPlace Earnings has automated the analysis of quarterly earnings using TradeSmith data, providing investors with comprehensive insights like EPS and revenue figures. These reports are driven by data to deliver the latest financial updates efficiently. For any feedback or corrections, reach us at editor@investorplace.com.


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/alpn-stock-earnings-alpine-immune-sciences-for-q4-of-2023/.

Β©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.